Publications by authors named "Joanna C Beachy"

Article Synopsis
  • This study investigates the transmission risk of SARS-CoV-2 in newborns born to mothers infected with the virus during the early months of the COVID-19 pandemic in New York.
  • It involved testing 293 newborns within 14 days of birth, focusing on those who were initially negative but later retested for the virus.
  • The findings showed low transmission rates, with only seven out of 222 retested newborns testing positive and none exhibiting symptoms, suggesting that breastfeeding is safe when proper hygiene is followed.
View Article and Find Full Text PDF

Background: Premature birth is associated with increased adipose deposition after birth. Standard anthropometry (body weight, length, and head circumference) may not adequately assess fat deposition. Validated methods to assess adiposity are needed to optimize growth quality in preterm infants.

View Article and Find Full Text PDF

Background: Despite therapeutic hypothermia, neonates with encephalopathy (NE) have high rates of death or disability. Darbepoetin alfa (Darbe) has comparable biological activity to erythropoietin, but has extended circulating half-life (t(1/2)). Our aim was to determine Darbe safety and pharmacokinetics as adjunctive therapy to hypothermia.

View Article and Find Full Text PDF

Pediatric traumatic brain injury (pTBI) is the leading cause of traumatic death and disability in children in the United States. Impaired learning and memory in these young survivors imposes a heavy toll on society. In adult TBI (aTBI) models, cognitive outcome improved after administration of erythropoietin (EPO) or insulin-like growth factor-1 (IGF-1).

View Article and Find Full Text PDF

Improvements in neonatal intensive care during the last 20 years have increased the survival of the most immature newborns at 23 weeks from 0% to 65% at some centres, although rates vary widely among neonatal care centres. University of Utah, USA data show that each week in utero after week 23 raises survival by 6-9%, to 90% by 27-28 weeks and 95% by 33 weeks. Provision of care in specialised centres to provide high-risk obstetric and neonatal intensive care, prenatal treatment with corticosteroids, postnatal treatment with surfactant and nitric oxide, and improvements in respirators and equipment to care for extremely immature infants all contribute to these changes.

View Article and Find Full Text PDF